Glutamic acid decarboxylase (GAD)based delivery systems

Details for Australian Patent Application No. 2004101085 (hide)

Owner Neurologix, Inc. Thomas Jefferson University

Inventors Kaplitt, Michael; During, Matthew John

Agent Pizzeys

Pub. Number AU-A-2004101085

Parent 2001268080

Filing date 23 December 2004

Opi date 3 February 2005

International Classifications

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 009/88 Enzymes, e.g. ligases (6.) - Lyases (4.)

C12N 015/60 Mutation or genetic engineering - Lyases (4)

Event Publications

13 January 2005 Innovation Patent Application Filed

3 February 2005 Innovation Patent Open to Public Inspection

  Published as AU-A-2004101085

3 February 2005 Innovation Patent Sealed

11 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143A(d), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004101086-Pump having an angle adjustable water outlet

2004101084-Anthelmintic compositions